Byetta Fallout Hits Novo Nordisk (That Pancreatitis Scare)
This morning Novo Nordisk announced that the FDA has scheduled an advisory committee meeting for its new Liraglutide once-daily GLP-1 drug, currently awaiting FDA approval. Believe it or not, this is huge news  - with the potential to make or bre... (Source: Diabetes Mine)
Source: Diabetes Mine - September 5, 2008 Category: Endocrinology Authors: Amy Tenderich Source Type: blogs

Byetta Fallout Hits Novo Nordisk (That Pancreatitis Scare)
This morning Novo Nordisk announced that the FDA has scheduled an advisory committee meeting for its new Liraglutide once-daily GLP-1 drug, currently awaiting FDA approval. Believe it or not, this is huge news - with the potential to make or bre... (Source: Diabetes Mine)
Source: Diabetes Mine - September 5, 2008 Category: Endocrinology Authors: Amy Tenderich Source Type: blogs